Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 37
Calif. Judge Dismisses Bextra, Celebrex Claims for Failure to Prosecute
Pfizer Says Dismissals from MDL's Discovery Pool Must be with Prejudice
Pfizer Says Sales Reps' Bonus, Performance Review Information Irrelevant
Parties Differ in Proposals for Repatriating Calif. Vioxx Cases
Defendant Says ERISA Preempts Vioxx Plaintiffs' State Law Claims
Arthritis Drugs - Issue: 36
Research Watch, Arthritis Drugs, May 2007
Arthritis Drugs - Issue: 37
MDL Court Appoints Special Master, Suspends Employee Depositions
Texas Judge Refuses to Order New Trial in $19.4 Million Remicade Case
